全文获取类型
收费全文 | 389514篇 |
免费 | 17245篇 |
国内免费 | 775篇 |
专业分类
耳鼻咽喉 | 3458篇 |
儿科学 | 12375篇 |
妇产科学 | 7429篇 |
基础医学 | 44364篇 |
口腔科学 | 6148篇 |
临床医学 | 32979篇 |
内科学 | 76332篇 |
皮肤病学 | 3573篇 |
神经病学 | 37143篇 |
特种医学 | 15902篇 |
外国民族医学 | 15篇 |
外科学 | 62133篇 |
综合类 | 5839篇 |
现状与发展 | 2篇 |
一般理论 | 300篇 |
预防医学 | 37310篇 |
眼科学 | 7532篇 |
药学 | 24400篇 |
1篇 | |
中国医学 | 1017篇 |
肿瘤学 | 29282篇 |
出版年
2023年 | 801篇 |
2022年 | 1229篇 |
2021年 | 3715篇 |
2020年 | 2266篇 |
2019年 | 3630篇 |
2018年 | 25552篇 |
2017年 | 20274篇 |
2016年 | 22577篇 |
2015年 | 5222篇 |
2014年 | 7190篇 |
2013年 | 10078篇 |
2012年 | 20669篇 |
2011年 | 35437篇 |
2010年 | 26663篇 |
2009年 | 18854篇 |
2008年 | 32970篇 |
2007年 | 35999篇 |
2006年 | 15066篇 |
2005年 | 17122篇 |
2004年 | 17625篇 |
2003年 | 17622篇 |
2002年 | 15340篇 |
2001年 | 2256篇 |
2000年 | 1967篇 |
1999年 | 2310篇 |
1998年 | 3149篇 |
1997年 | 2721篇 |
1996年 | 2359篇 |
1995年 | 2128篇 |
1994年 | 1940篇 |
1993年 | 1779篇 |
1992年 | 1334篇 |
1991年 | 1303篇 |
1990年 | 1223篇 |
1989年 | 1099篇 |
1988年 | 1128篇 |
1987年 | 1090篇 |
1986年 | 1073篇 |
1985年 | 1167篇 |
1984年 | 1546篇 |
1983年 | 1528篇 |
1982年 | 1901篇 |
1981年 | 1691篇 |
1980年 | 1633篇 |
1979年 | 866篇 |
1978年 | 1008篇 |
1977年 | 966篇 |
1976年 | 863篇 |
1975年 | 702篇 |
1974年 | 707篇 |
排序方式: 共有10000条查询结果,搜索用时 272 毫秒
31.
32.
33.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献
34.
35.
36.
M. Alexandra Friedman Charlotte M. Niznik Janelle R. Bolden Lynn M. Yee 《Journal of community health》2016,41(2):354-358
While peer support has been investigated in multiple clinical contexts, its application to the postpartum setting is unknown. The aim was to assess acceptability of a postpartum peer support program for women with diabetes. Observational survey-based needs assessment of forty low-income women with diabetes, receiving care at a major medical institution. Mean age and gravidity were 30.7 years and 3.15 ± 1.67 respectively. 45 % expressed interest in a “buddy.” There was no significant difference between groups desiring and not desiring this program. A majority of respondents desired telephone, text messaging, and in-person contacts (79.2, 72.1, 83.8 %), with 72.5 % of patients desiring diabetes-related activities during clinic waiting time. Many women desire a postpartum diabetes reciprocal peer program for support outside of clinician visits. Patients are receptive to educational services during their wait and outside of clinic time, a potentially valuable opportunity to share important health information. 相似文献
37.
Christopher Yeh Cem Atillasoy John T. Seykora Vivian Lee 《Journal of cutaneous pathology》2021,48(1):171-173
Respiratory cysts are benign lesions lined by normal respiratory epithelium. There are few reported cases localized to the orbit, while those of the eyelid are exceedingly rare. Respiratory cysts usually arise either from a non‐hereditary congenital malformation, where they are distinguished as choristomatous, or from trauma. Here, we report a case of a 53‐year‐old man who presented with a large right lower eyelid cyst that was histopathologically diagnosed as a respiratory cyst. 相似文献
38.
Turnbull Chris D. Stockley James A. Madathil Shyam Huq Syed S. A. Cooper Brendan G. Ali Asad Wharton Simon Stradling John R. Heitmar Rebekka 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(7):2129-2139
Graefe's Archive for Clinical and Experimental Ophthalmology - Retinal microvascular endothelial dysfunction is thought to be of importance in the development of ocular vascular diseases.... 相似文献
39.
Michael W. Manning Yi-Ju Li Dean Linder John C. Haney Yi-Hung Wu Mihai V. Podgoreanu Madhav Swaminathan Jacob N. Schroder Carmelo A. Milano Ian J. Welsby Mark Stafford-Smith Kamrouz Ghadimi 《Journal of cardiothoracic and vascular anesthesia》2021,35(5):1310-1318
- Download : Download high-res image (215KB)
- Download : Download full-size image
40.
Shylo R. Johnson Dennis Slate Kathleen M. Nelson Amy J. Davis Samual A. Mills John T. Forbes Kurt C. VerCauteren Amy T. Gilbert Richard B. Chipman 《Viruses》2021,13(2)
Since the 1990s, oral rabies vaccination (ORV) has been used successfully to halt the westward spread of the raccoon rabies virus (RV) variant from the eastern continental USA. Elimination of raccoon RV from the eastern USA has proven challenging across targeted raccoon (Procyon lotor) and striped skunk (Mephitis mephitis) populations impacted by raccoon RV. Field trial evaluations of the Ontario Rabies Vaccine Bait (ONRAB) were initiated to expand ORV products available to meet the rabies management goal of raccoon RV elimination. This study describes the continuation of a 2011 trial in West Virginia. Our objective was to evaluate raccoon and skunk response to ORV occurring in West Virginia for an additional two years (2012–2013) at 75 baits/km2 followed by three years (2014–2016) of evaluation at 300 baits/km2. We measured the change in rabies virus-neutralizing antibody (RVNA) seroprevalence in targeted wildlife populations by comparing levels pre- and post-ORV during each year of study. The increase in bait density from 75/km2 to 300/km2 corresponded to an increase in average post-ORV seroprevalence for raccoon and skunk populations. Raccoon population RVNA levels increased from 53% (300/565, 95% CI: 50–57%) to 82.0% (596/727, 95% CI: 79–85%) during this study, and skunk population RVNA levels increased from 11% (8/72, 95% CI: 6–20%) to 39% (51/130, 95% CI: 31–48%). The RVNA seroprevalence pre-ORV demonstrated an increasing trend across study years for both bait densities and species, indicating that multiple years of ORV may be necessary to achieve and maintain RVNA seroprevalence in target wildlife populations for the control and elimination of raccoon RV in the eastern USA. 相似文献